IN2012DN03310A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03310A IN2012DN03310A IN3310DEN2012A IN2012DN03310A IN 2012DN03310 A IN2012DN03310 A IN 2012DN03310A IN 3310DEN2012 A IN3310DEN2012 A IN 3310DEN2012A IN 2012DN03310 A IN2012DN03310 A IN 2012DN03310A
- Authority
- IN
- India
- Prior art keywords
- moeties
- peptiod
- tetrapeptide
- tripeptide
- dipeptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0918579.4A GB0918579D0 (en) | 2009-10-22 | 2009-10-22 | Gadd45beta targeting agents |
PCT/GB2010/001970 WO2011048390A2 (en) | 2009-10-22 | 2010-10-22 | Gadd45beta targeting agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN03310A true IN2012DN03310A (en) | 2015-10-23 |
Family
ID=41426579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3310DEN2012 IN2012DN03310A (en) | 2009-10-22 | 2010-10-22 |
Country Status (14)
Country | Link |
---|---|
US (2) | US8993717B2 (en) |
EP (2) | EP3178836B1 (en) |
JP (2) | JP5961113B2 (en) |
KR (1) | KR20120099440A (en) |
CN (1) | CN102741269B (en) |
AU (1) | AU2010309594B2 (en) |
BR (1) | BR112012011332B1 (en) |
CA (2) | CA3034860A1 (en) |
GB (1) | GB0918579D0 (en) |
IL (1) | IL219325B (en) |
IN (1) | IN2012DN03310A (en) |
MX (1) | MX357801B (en) |
RU (2) | RU2577311C2 (en) |
WO (1) | WO2011048390A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0918579D0 (en) | 2009-10-22 | 2009-12-09 | Imp Innovations Ltd | Gadd45beta targeting agents |
PL219569B1 (en) | 2010-02-19 | 2015-05-29 | Peptaderm Spółka Z Ograniczoną Odpowiedzialnością | Cyclic tetrapeptides and their application |
GB201107118D0 (en) * | 2011-04-27 | 2011-06-08 | Imp Innovations Ltd | Method of diagnosis and prognosis |
WO2013055051A1 (en) * | 2011-10-14 | 2013-04-18 | 서울대학교산학협력단 | Peptide nanostructure and a production method therefor |
DK3777876T3 (en) | 2011-10-28 | 2023-10-30 | Neostrata Company Inc | N-acyl dipeptide derivatives and uses thereof |
WO2013142376A1 (en) * | 2012-03-19 | 2013-09-26 | Aposignal Bioscience Llc | Composition and methods for cell modulation |
CN104817616A (en) * | 2014-01-30 | 2015-08-05 | 陈光健 | Oligopeptide CD02, and preparation method and application thereof |
CN104817618B (en) * | 2014-01-30 | 2018-07-03 | 陈光健 | Oligopeptides CD01 and its preparation method and application |
GB201414542D0 (en) * | 2014-08-15 | 2014-10-01 | Imp Innovations Ltd | Novel therapy |
CN111574585B (en) * | 2019-01-30 | 2021-10-01 | 浙江省医学科学院 | Cod skin oligopeptide and separation and purification method and application thereof |
RU2716258C1 (en) * | 2019-07-30 | 2020-03-11 | Автономная некоммерческая образовательная организация высшего образования Сколковский институт науки и технологий | Peptide antagonist of the nmda receptor |
KR102417496B1 (en) * | 2019-11-29 | 2022-07-06 | (주)수파드엘릭사 | Peptide for inhibiting activity of androgen receptor and Cosmetic composition using the same |
WO2021194228A1 (en) * | 2020-03-23 | 2021-09-30 | 주식회사 엘베이스 | Pharmaceutical composition for prevention or treatment of cancer |
KR102348728B1 (en) * | 2020-03-23 | 2022-01-12 | 주식회사 엘베이스 | Pharmaceutical Composition for the Prevention or Treatment of Cancer |
KR20230038457A (en) | 2020-06-10 | 2023-03-20 | 알리고스 테라퓨틱스 인코포레이티드 | Antiviral compounds for treating coronavirus, picornavirus and norovirus infections |
JP2023522311A (en) * | 2021-03-22 | 2023-05-30 | エル-ベース カンパニー リミテッド | Pharmaceutical composition for cancer prevention or treatment |
WO2022203219A1 (en) * | 2021-03-22 | 2022-09-29 | 주식회사 엘베이스 | Pharmaceutical composition for prevention or treatment of cancer |
IL309732A (en) | 2021-07-09 | 2024-02-01 | Aligos Therapeutics Inc | Anti-viral compounds |
IT202100023357A1 (en) * | 2021-09-09 | 2023-03-09 | Cheirontech S R L | Peptides with anti-angiogenic activity |
WO2023043269A1 (en) * | 2021-09-17 | 2023-03-23 | 주식회사 엘베이스 | Pharmaceutical composition for modulating immune response |
KR102494749B1 (en) * | 2021-09-17 | 2023-02-06 | 주식회사 엘베이스 | Method of characterizing responders to CAGE inhibitors for treatment of cancer |
WO2023043261A1 (en) * | 2021-09-17 | 2023-03-23 | 주식회사 엘베이스 | Pharmaceutical composition for enhancing anticancer effect of anticancer drug |
CN116350746B (en) * | 2023-05-16 | 2024-03-22 | 海口桥水联合科技有限责任公司 | Application of sardine peptide composition in medicines for treating allergic rhinitis |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
HU187461B (en) | 1981-10-22 | 1986-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for producing n-nitrozo-n-bracket-beta-chloroethyl-bracket closed-carbamoyl-peptides of citostatic activity |
CA1257199A (en) | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
DE3813989A1 (en) * | 1987-04-29 | 1988-11-10 | Hoechst Ag | Peptides with phospholipase A2-inhibiting action |
IT1243390B (en) | 1990-11-22 | 1994-06-10 | Vectorpharma Int | PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION. |
US5907030A (en) | 1995-01-25 | 1999-05-25 | University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
US5962270A (en) | 1996-02-06 | 1999-10-05 | Bionebraska, Inc. | Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs |
US6737408B1 (en) * | 1997-08-07 | 2004-05-18 | University Of Cincinnati | Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
US6093692A (en) | 1997-09-25 | 2000-07-25 | The University Of Southern California | Method and compositions for lipidization of hydrophilic molecules |
FR2774674B1 (en) | 1998-02-10 | 2000-03-24 | Atochem Elf Sa | PROCESS FOR THE PREPARATION OF AN AQUEOUS SOLUTION OF HYDROGEN PEROXIDE DIRECTLY FROM HYDROGEN AND OXYGEN AND DEVICE FOR IMPLEMENTING SAME |
US5993414A (en) | 1998-04-23 | 1999-11-30 | Medtronic, Inc. | Implantable device |
US20030162223A1 (en) * | 1999-10-22 | 2003-08-28 | Lowery David E. | Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
US6436091B1 (en) | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
US7723303B2 (en) * | 2000-08-24 | 2010-05-25 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
CA2447314A1 (en) | 2001-05-15 | 2002-11-21 | Atsuro Nakazato | Arginine derivatives |
ES2345842T3 (en) * | 2001-07-13 | 2010-10-04 | Cms Peptides Patent Holding Company Limited | BIOLOGICALLY ACTIVE PEPTIDES. |
WO2003028659A2 (en) | 2001-10-02 | 2003-04-10 | University Of Chicago | Methods and compositions for modulating apoptosis |
US7354898B2 (en) * | 2001-10-02 | 2008-04-08 | University Of Chicago | Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
CN1675374A (en) | 2002-08-19 | 2005-09-28 | 阎云 | Treatment of liver diseases |
CN1809590A (en) | 2003-04-22 | 2006-07-26 | 阿文尼尔药品公司 | Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
US7084111B2 (en) * | 2003-06-23 | 2006-08-01 | University Of Florida Research Foundation, Inc. | Melanocortin receptor templates, peptides, and use thereof |
WO2006049597A1 (en) * | 2004-10-27 | 2006-05-11 | Avanir Pharmaceuticals | Amino acid-derived compounds as modulators of the reverse cholesterol transport |
AP2616A (en) | 2005-01-13 | 2013-03-18 | Univ Wollongong | Peptidic compounds |
DK1853620T3 (en) | 2005-02-09 | 2012-03-26 | Helix Biomedix Inc | Antimicrobial hexapeptides |
EP1865950B1 (en) * | 2005-04-07 | 2013-08-28 | Centre National de la Recherche Scientifique | Compounds useful as modulators of the proteasome activity |
US20080293639A1 (en) * | 2005-04-29 | 2008-11-27 | The Regents Of The University Of California | Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response |
US7951782B2 (en) * | 2005-09-29 | 2011-05-31 | Maruha Nichiro Seafoods, Inc | Composition effective to prevent or treat adult disease |
JP2007217358A (en) * | 2006-02-17 | 2007-08-30 | Nippon Meat Packers Inc | Anti-oxidizing peptide |
WO2007117444A2 (en) * | 2006-03-31 | 2007-10-18 | Yinghe Hu | Protein detection by aptamers |
US20090312396A1 (en) | 2006-07-10 | 2009-12-17 | Astrazeneca Ab | Methods for cancer treatment using tak1 inhibitors |
AU2007284801A1 (en) * | 2006-08-08 | 2008-02-21 | The Regents Of The University Of Californina | Salicylanilides enhance oral delivery of therapeutic peptides |
CN101153053B (en) * | 2006-09-28 | 2012-02-01 | 中国医学科学院药物研究所 | Bone-peptide, producing method, pharmaceutical composition and uses thereof |
EP1964560A1 (en) | 2007-02-28 | 2008-09-03 | Helmholtz-Zentrum für Infektionsforschung GmbH | Use of inhibitors of the degradation of p27 for the treatment of cancer |
GB2471588A (en) | 2008-02-08 | 2011-01-05 | Aileron Therapeutics Inc | Therapeutic peptidomimetic macrocycles |
GB0918579D0 (en) | 2009-10-22 | 2009-12-09 | Imp Innovations Ltd | Gadd45beta targeting agents |
EP2390662A1 (en) | 2010-05-27 | 2011-11-30 | Erasmus University Medical Center Rotterdam | Molecular classification of multiple myeloma |
-
2009
- 2009-10-22 GB GBGB0918579.4A patent/GB0918579D0/en not_active Ceased
-
2010
- 2010-10-22 EP EP16185463.3A patent/EP3178836B1/en active Active
- 2010-10-22 BR BR112012011332-1A patent/BR112012011332B1/en active IP Right Grant
- 2010-10-22 CA CA3034860A patent/CA3034860A1/en not_active Abandoned
- 2010-10-22 CN CN201080058254.9A patent/CN102741269B/en active Active
- 2010-10-22 IN IN3310DEN2012 patent/IN2012DN03310A/en unknown
- 2010-10-22 RU RU2012120905/04A patent/RU2577311C2/en active
- 2010-10-22 KR KR1020127013065A patent/KR20120099440A/en not_active Application Discontinuation
- 2010-10-22 WO PCT/GB2010/001970 patent/WO2011048390A2/en active Application Filing
- 2010-10-22 MX MX2012004755A patent/MX357801B/en active IP Right Grant
- 2010-10-22 JP JP2012534766A patent/JP5961113B2/en active Active
- 2010-10-22 AU AU2010309594A patent/AU2010309594B2/en active Active
- 2010-10-22 CA CA2778236A patent/CA2778236A1/en not_active Abandoned
- 2010-10-22 RU RU2016102083A patent/RU2016102083A/en not_active Application Discontinuation
- 2010-10-22 EP EP10781977A patent/EP2491051A2/en not_active Withdrawn
- 2010-10-22 US US13/502,781 patent/US8993717B2/en active Active
-
2012
- 2012-04-22 IL IL219325A patent/IL219325B/en not_active IP Right Cessation
-
2015
- 2015-02-10 US US14/618,613 patent/US9518083B2/en active Active
-
2016
- 2016-03-25 JP JP2016060994A patent/JP2016166211A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112012011332A2 (en) | 2016-11-22 |
WO2011048390A3 (en) | 2011-11-03 |
US20150368294A1 (en) | 2015-12-24 |
CN102741269A (en) | 2012-10-17 |
US9518083B2 (en) | 2016-12-13 |
CA2778236A1 (en) | 2011-04-28 |
RU2012120905A (en) | 2013-11-27 |
CA3034860A1 (en) | 2011-04-28 |
AU2010309594B2 (en) | 2016-01-07 |
MX2012004755A (en) | 2012-11-22 |
EP2491051A2 (en) | 2012-08-29 |
JP2013508346A (en) | 2013-03-07 |
WO2011048390A2 (en) | 2011-04-28 |
EP3178836A1 (en) | 2017-06-14 |
KR20120099440A (en) | 2012-09-10 |
US20120277164A1 (en) | 2012-11-01 |
JP2016166211A (en) | 2016-09-15 |
JP5961113B2 (en) | 2016-08-02 |
CN102741269B (en) | 2017-08-29 |
IL219325B (en) | 2019-02-28 |
BR112012011332B1 (en) | 2022-07-05 |
RU2577311C2 (en) | 2016-03-20 |
IL219325A0 (en) | 2012-06-28 |
MX357801B (en) | 2018-07-25 |
EP3178836B1 (en) | 2019-12-25 |
RU2016102083A (en) | 2018-11-20 |
US8993717B2 (en) | 2015-03-31 |
GB0918579D0 (en) | 2009-12-09 |
AU2010309594A1 (en) | 2012-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN03310A (en) | ||
PH12014500053A1 (en) | Proteasome inhibitors | |
MY163275A (en) | Ibat inhibitors for the treatment of liver diseases | |
EP2528934A4 (en) | Aromatic-cationic peptides and uses of same | |
PH12015500832A1 (en) | Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof | |
MX350046B (en) | Treatments for gastrointestinal disorders. | |
EA201101522A1 (en) | METHODS OF TREATMENT OF DISEASES WITH THE USE OF EPIMETABOLIC SWITCH (COENZIM Q10) | |
EP2582722A4 (en) | Anti-gd2 antibodies | |
IN2012MN02591A (en) | ||
PH12018500639A1 (en) | Optimized monoclonal antibodies agaist tissue factor pathway inhibitor (tfpi) | |
MX2009006704A (en) | New compounds. | |
MX366130B (en) | Bivalent inhibitors of iap proteins and therapeutic methods using the same. | |
MX2009006327A (en) | Heterocycle compounds and methods of use thereof. | |
EA201390803A1 (en) | Bromodomain inhibitors and their use | |
PL3208612T3 (en) | Compositions and methods for the treatment of immune related diseases | |
HK1148945A1 (en) | Methods and compositions for oral administration of protein and peptide therapeutic agents | |
MX2011009033A (en) | Tri-cyclic pyrazolopyridine kinase inhibitors. | |
MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
MX347734B (en) | S100a4 antibodies and therapeutic uses thereof. | |
MX2011013032A (en) | Inhibitors of phosphatidylinositol 3-kinase. | |
EP2217238A4 (en) | Methods and compositions for the treatment of proteinuric diseases | |
HK1162502A1 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3 | |
HK1171677A1 (en) | Composition for the treatment of hemorrhoids and related diseases | |
WO2010135521A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
EP2294197A4 (en) | Variant hhip1 protein and methods and uses thereof |